FDA Approves Acculasers Carpal Tunnel Technology

SAN DIEGO, Aug. 6 -- Acculaser Inc. has received approval from the Food and Drug Administration to market the company's Acculaser Pro Cold Laser for use in the non-surgical treatment and management of pain for carpal tunnel syndrome.

"We are very excited to be able to offer this innovative non-surgical approach to people suffering from carpal tunnel pain," said Jackson Streeter CEO of Acculaser.

Acculaser is also pursuing FDA clearance for treatment of tendonitis, and is conducting animal research in the area of bone regeneration in collaboration with the Medical College of Wisconsin.